Skip to content

Clinical trials

Phase 4 Mental Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 4 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20051
20061
20091
20113
20124
20131
20153
20193

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Withdrawn3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
University of North Carolina, Chapel Hill2
Emory University1
Indiana University1
Johns Hopkins University1
Massachusetts General Hospital1
Mclean Hospital1
NYU Langone Health1
National Institute of Mental Health (NIMH)1
Oregon Health and Science University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders21
Psychotic Disorders5
Schizophrenia5
Depressive Disorder3
Mood Disorders3
Substance-Related Disorders3
Alcohol-Related Disorders2
Alcoholism2
Dementia2
Tobacco Use Disorder2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.